Phio Pharmaceuticals Corp Stock Market Value
| PHIO Stock | USD 1.29 0.17 15.18% |
| Symbol | Phio |
Will Biotechnology sector continue expanding? Could Phio diversify its offerings? Factors like these will boost the valuation of Phio Pharmaceuticals. Anticipated expansion of Phio directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Phio Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Phio Pharmaceuticals Corp's market price often diverges from its book value, the accounting figure shown on Phio's balance sheet. Smart investors calculate Phio Pharmaceuticals' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Phio Pharmaceuticals' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Phio Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Phio Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Phio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Phio Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Phio Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Phio Pharmaceuticals.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in Phio Pharmaceuticals on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding Phio Pharmaceuticals Corp or generate 0.0% return on investment in Phio Pharmaceuticals over 90 days. Phio Pharmaceuticals is related to or competes with Transcode Therapeutics, Kiora Pharmaceuticals, In8bio, Biocardia, Aprea Therapeutics, Marker Therapeutics, and Galecto. Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States More
Phio Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Phio Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Phio Pharmaceuticals Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 19.15 | |||
| Value At Risk | (7.53) | |||
| Potential Upside | 6.98 |
Phio Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Phio Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Phio Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Phio Pharmaceuticals historical prices to predict the future Phio Pharmaceuticals' volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.26) | |||
| Total Risk Alpha | (0.72) | |||
| Treynor Ratio | (0.04) |
Phio Pharmaceuticals February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | (0.03) | |||
| Mean Deviation | 3.68 | |||
| Coefficient Of Variation | (7,625) | |||
| Standard Deviation | 5.39 | |||
| Variance | 29.01 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | (0.26) | |||
| Total Risk Alpha | (0.72) | |||
| Treynor Ratio | (0.04) | |||
| Maximum Drawdown | 19.15 | |||
| Value At Risk | (7.53) | |||
| Potential Upside | 6.98 | |||
| Skewness | 1.44 | |||
| Kurtosis | 6.56 |
Phio Pharmaceuticals Corp Backtested Returns
Phio Pharmaceuticals Corp maintains Sharpe Ratio (i.e., Efficiency) of close to zero, which implies the firm had a close to zero % return per unit of risk over the last 3 months. Phio Pharmaceuticals Corp exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Phio Pharmaceuticals' Coefficient Of Variation of (7,625), insignificant risk adjusted performance, and Variance of 29.01 to confirm the risk estimate we provide. The company holds a Beta of 1.9, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Phio Pharmaceuticals will likely underperform. At this point, Phio Pharmaceuticals Corp has a negative expected return of -0.0318%. Please make sure to check Phio Pharmaceuticals' maximum drawdown, as well as the relationship between the daily balance of power and period momentum indicator , to decide if Phio Pharmaceuticals Corp performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.31 |
Below average predictability
Phio Pharmaceuticals Corp has below average predictability. Overlapping area represents the amount of predictability between Phio Pharmaceuticals time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Phio Pharmaceuticals Corp price movement. The serial correlation of 0.31 indicates that nearly 31.0% of current Phio Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.31 | |
| Spearman Rank Test | 0.31 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Pair Trading with Phio Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Phio Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phio Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Phio Stock
| 0.66 | EDIT | Editas Medicine Earnings Call Next Week | PairCorr |
Moving against Phio Stock
| 0.73 | DSGN | Design Therapeutics | PairCorr |
| 0.68 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.54 | ENGN | enGene Holdings Common | PairCorr |
| 0.51 | KYTX | Kyverna Therapeutics | PairCorr |
| 0.33 | 63E | ONWARD MEDICAL BV | PairCorr |
The ability to find closely correlated positions to Phio Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Phio Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Phio Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Phio Pharmaceuticals Corp to buy it.
The correlation of Phio Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Phio Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Phio Pharmaceuticals Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Phio Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Phio Pharmaceuticals Correlation, Phio Pharmaceuticals Volatility and Phio Pharmaceuticals Performance module to complement your research on Phio Pharmaceuticals. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Phio Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.